Skip to main content

and
  1. No Access

    Article

    AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges

    The new entry inhibitor eCD4-Ig, consisting of the immunoadhesin form of CD4 (CD4-Ig) fused to a small CCR5-mimetic sulfopeptide, avidly binds two highly conserved sites of the HIV-1 Env protein; the inhibitor...

    Matthew R. Gardner, Lisa M. Kattenhorn, Hema R. Kondur, Markus von Schaewen in Nature (2015)